U.S. Heparin Market Report 2020-2026 by Regional Revenue, Growth & Trends Analysis

1
U.S. Heparin Market Report 2020-2026 by Regional
Revenue, Growth Trends Analysis

• With burgeoning demand for anticoagulant drugs
  driven by the rising prevalence of coronary
  artery diseases and venous thromboembolism, U.S.
  heparin market is poised to gain major momentum
  over the ensuing years. According to the Society
  of Thoracic Surgeons database, approximately
  200,000 cases of coronary artery bypass grafting
  (CABG) are reported annually in the U.S.
  Furthermore, the number of cardiac surgeries
  involving either CABG procedures or valve
  replacement and repair procedures rose by over
  6.5 during the same time span.
• With the increasing number of such procedures,
  demand for heparin anticoagulant is likely to
  increase tremendously over the foreseeable
  future. According to the Global Market Insights,
  Inc. report, U.S. heparin market size is
  projected to surpass USD 1.0 billion at a
  significant growth rate of 7.2 through 2026.

2017 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
2

• In terms of product, the low molecular weight
  heparin segment accounted for a substantial
  valuation of USD 535.4 million in the past and is
  anticipated to dominate the market over the
  subsequent years. This can be attributed to the
  extensive use of low molecular weight heparin in
  coagulation disorders treatment as well as in
  surgical procedures. Besides, the increasing
  prevalence of deep vein thrombosis (DVT) will
  also impel the demand for low molecular weight
  heparin.

• Based on the application spectrum, the coronary
  artery disease segment had recorded an
  appreciable valuation of USD 148.5 million in
  2019 and is expected to grow over time. The
  growth can be credited to increasing demand for
  heparin treatment due to the rising incidence of
  coronary artery disease in the country. Based on
  a report by the Center for Disease Control and
  Prevention, coronary heart disease (CAD) is the
  most common heart disease in U.S., resulting in
  around 365,914 deaths in 2017. Further, the
  report also mentions that over 18.2 million
  adults in the age group of 20 years and above are
  suffering from CAD.

• U.S heparin market is highly characterized by the
  online pharmacy segment, which according to
  numerous reports is estimated to grow
  exponentially over the upcoming years owing to
  the numerous benefits associated with it such as
  availability of a wide range of products,
  discounts, easy mobilization and doorstep
  delivery. . Such benefits are likely to attract a
  large consumer base.

2017 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
3
Request for a Sample Copy of this Report _at_
https//www.gminsights.com/request-sample/detail/4
868
2017 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
4

• Competitive Analysis

• Apart from the above-mentioned segments and the
  growth inducing factors associated with them,
  strategic initiatives undertaken by the business
  players are also significantly contributing to
  the industry growth. Prominent industry players
  operating in U.S. heparin industry such as
  Amphastar Pharmaceutical, Pfizer, Sanofi,
  Fresenius Kabi, Shenzhen Hepalink, etc. are
  focusing on strategic partnerships, acquisitions,
  geographical expansion and new product launches
  to strengthen their market position. For
  instance, in 2019, Fresenius Kabi announced its
  plans of distributing preservative-free Heparin
  Sodium Injection named Simplist in the U.S.
  According to the company, the product will be
  available in 5,000 USP units per 0.5 mL in the
  form of ready-to-administer prefilled syringes.
  Apparently, this initiative helped the company in
  expanding its geographical footprint.
• Citing another instance regarding strategic
  partnership, in 2020, Premier Inc. announced its
  partnership with Fresenius Kabi through its
  ProvideGx program aimed at providing the
  healthcare professionals with single-use,
  pre-filled IV bags of heparin sodium injection,
  to manage the long-term supply of medication that
  is required while performing various hospital
  inpatient procedures.

2017 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
5
Latest Research Report On U.S. Heparin Market _at_
https//www.gminsights.com/industry-analysis/us-he
parin-market
Request for sample of this research report_at_
https//www.gminsights.com/request-sample/detail/
4868
Request for customization https//www.gminsights
.com/roc/4868
2017 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
6
Stay In Touch You can visit us at
www.gminsights.com
Thank You!
2017 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
www.gminsights.com